1 in 14 Patients Require Arrhythmia Intervention: Remote Patient Management with the Wearable Cardioverter Defibrillator EHRA EUROPACECARDIOSTIM 2015 Satellite Symposium 23 June 2015 12:45 – 13:45 Room: Venezia Faculty Chairpersons PD Dr. Johannes Sperzel Bad Nauheim, Germany Prof. Jean-Claude Deharo Marseille, France Speakers Dr. Oliver Przibille Frankfurt, Germany PD Dr. Jan Steffel Zurich, Switzerland With the online patient management system, you can diagnose arrhythmic events including: + Sustained VT + Non-sustained VT + Atrial arrhythmias/SVT + Severe bradycardia/Asystole www.zoll.com/EHRAEUROPACE-CARDIOSTIM2015 Program Overview This program will discuss how the wearable cardioverter defibrillator (WCD) provides protection from Sudden Cardiac Death with a connection to your patients’ changing cardiac condition through the online patient management system. Arrhythmic events captured in the online patient management system provide actionable insights and the opportunity to modify the treatment path for patients protected by the WCD. Program Agenda MINUTES PRESENTER OBJECTIVE 10 All Faculty Introduction 15 PD Dr. Jan Steffel Discussion of the utility of remotely managed patient clinical and diagnostic markers to effect better outcomes 15 Dr. Oliver Przibille Overview of the online patient management system and clinical case scenarios for its use in treating patients in addition to shocking VT/VF 20 All Faculty Panel Discussion/Q&A Reference: Kutyifa V, Goldenberg I, Zareba W, et al. Results from the prospective registry of patients using the wearable defibrillator (WEARIT-II Registry). Presented as Late Breaking Clinical Trial at ESC Congress 2014, Sept 3, 2014. © 2015 ZOLL Medical Corporation. ZOLL and LifeVest are registered trademarks of ZOLL Medical Corporation in the United States and/or other countries. 20C0466 Rev FI
© Copyright 2024